procaterol has been researched along with Cirrhosis in 1 studies
Procaterol: A long-acting beta-2-adrenergic receptor agonist.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The pathogenesis of chronic obstructive pulmonary disease is related to fibrosis around the small airways." | 1.35 | Procaterol inhibits lung fibroblast migration. ( Desaki, M; Itakura, S; Kamitani, S; Kawasaki, S; Kohyama, T; Nagase, T; Takizawa, H; Yamauchi, Y, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kohyama, T | 1 |
| Yamauchi, Y | 1 |
| Takizawa, H | 1 |
| Itakura, S | 1 |
| Kamitani, S | 1 |
| Desaki, M | 1 |
| Kawasaki, S | 1 |
| Nagase, T | 1 |
1 other study available for procaterol and Cirrhosis
| Article | Year |
|---|---|
Procaterol inhibits lung fibroblast migration.
Topics: Cell Migration Inhibition; Cells, Cultured; Fibroblasts; Fibrosis; Humans; Inflammation Mediators; L | 2009 |